These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6223766)

  • 1. Circulating T-cell subsets in Graves' disease: differences between patients with active disease and in remission after 131I-therapy.
    Canonica GW; Bagnasco M; Ferrini S; Biassoni P; Giordano G; Corte G
    Clin Immunol Immunopathol; 1983 Aug; 28(2):265-71. PubMed ID: 6223766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating T cell subsets in euthyroid Graves' disease.
    Bagnasco M; Canonica GW; Ferrini S; Ciprandi G; Dirienzo W; Giordano G; Ferrini O
    J Endocrinol Invest; 1983 Apr; 6(2):119-23. PubMed ID: 6223066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.
    Bagnasco M; Canonica GW; Ferrini S; Biassoni P; Melioli G; Ferrini O; Giordano G
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):213-9. PubMed ID: 6187169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
    Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
    J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of circulating T cell subsets in atopy: influence of specific immunotherapy.
    Canonica GW; Dirienzo W; Cosulich E; Ferrini S; Ciprandi G; Melioli G
    Int Arch Allergy Appl Immunol; 1983; 71(4):300-3. PubMed ID: 6602773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.
    Karlsson FA; Tötterman TH
    Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ia+ T cells in new onset Graves' disease.
    Jackson RA; Haynes BF; Burch WM; Shimizu K; Bowring MA; Eisenbarth GS
    J Clin Endocrinol Metab; 1984 Aug; 59(2):187-90. PubMed ID: 6610685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
    Ohashi H; Okugawa T; Itoh M
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.
    Jansson R; Karlsson A; Forsum U
    Clin Exp Immunol; 1984 Nov; 58(2):264-72. PubMed ID: 6238731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
    Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
    Chan JY; Walfish PG
    Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
    Chan JY; Walfish PG
    J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of T cell subset imbalance in relatives of Graves' disease patients.
    Biassoni P; Ciprandi G; Ferrini S; Chimini G; Canonica GW; Bagnasco M
    J Endocrinol Invest; 1984 Apr; 7(2):141-5. PubMed ID: 6609952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood T cell activation after radioiodine treatment for Graves' disease.
    Teng WP; Stark R; Munro AJ; Young SM; Borysiewicz LK; Weetman AP
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):233-40. PubMed ID: 2316311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.
    Canonica GW; Caria M; Torre G; Risso A; Cosulich ME; Bagnasco M
    J Endocrinol Invest; 1984 Dec; 7(6):641-5. PubMed ID: 6335716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathyroidal activated (Ia+) T-lymphocyte CD+ subsets and B cells in Graves' hyperthyroidism respond rapidly to propylthiouracil therapy: demonstration using fine needle aspirates and two-colour laser flow cytometry.
    Walfish PG; Tseng KH
    Autoimmunity; 1992; 13(1):35-41. PubMed ID: 1420805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.
    Bagnasco M; Macchia E; Ciprandi G; Caria M; Fenzi GF
    J Endocrinol Invest; 1986 Jun; 9(3):217-21. PubMed ID: 2876022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.